| Previous Close | 0.86 |
| Open | 1.26 |
| Day High | 1.39 |
| Day Low | 1.15 |
| 52-Week High | 5.88 |
| 52-Week Low | 0.65 |
| Volume | 46.58M |
| Average Volume | 1.27M |
| Market Cap | 5.83M |
| PE | -0.59 |
| EPS | -2.07 |
| Moving Average 50 Days | 0.83 |
| Moving Average 200 Days | 1.92 |
| Change | 0.36 |
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID
GlobeNewswire Inc.
Mar 11, 2026 12:45 PM GMT
Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB
Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026
GlobeNewswire Inc.
Mar 02, 2026 1:45 PM GMT
SPRING BRANCH, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, sto
Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026
GlobeNewswire Inc.
Feb 27, 2026 1:45 PM GMT
SPRING BRANCH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, stor